Condé Nast Portfolio

Pfizer, Incorporated (PFE)

SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Jeffrey B. Kindler , CEO/Chairman of the Board/Director
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Jeffrey B. Kindler, CEO/Chairman of the Board/Director

235 East 42nd Street

New York, NY 10017

US Map it

Phone: (212) 573-2323

Fax: (212) 573-7851

www.pfizer.com

Latest news from Portfolio


Overview

A research-based, global pharmaceutical company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

Portfolio Articles

See more news on this company

Portfolio Blogs
News From Around the Web
powered by  inform

Employees

Number of Employees: 86,600
Revenue per Employee: $496,051

Financials

Quarterly
Annual

Income Statement 01/2009 10/2008 07/2008 04/2008
Sales 2.32 Bil. 2.74 Bil. 2.95 Bil. 2.76 Bil.
Gross Operating Profit 10.03 Bil. 9.23 Bil. 9.18 Bil. 9.08 Bil.
Operating Income before D & A (EBITDA) 4.06 Bil. 3.82 Bil. 3.35 Bil. 3.8 Bil.
Total Income Before Interest Expenses (EBIT) 4.06 Bil. 2.72 Bil. 2.79 Bil. 3.56 Bil.
Total Net Income 226 Mil. 2.28 Bil. 2.78 Bil. 2.78 Bil.
Basic EPS, Total 0.04 0.34 0.41 0.41
Diluted EPS, Total 0.04 0.34 0.41 0.41

BALANCE STATEMENT 01/2009 10/2008 07/2008 04/2008
Cash and Equivalents NA NA NA NA
Total Assets NA NA NA NA
Total Liabilities NA NA NA NA
Total Capitalization NA NA NA NA

Cash Flow 01/2009 10/2008 07/2008 04/2008
Net Cash From Continuing Operations NA NA NA NA
Net Cash From Investing Activities NA NA NA NA
Net Cash From Financing Activities NA NA NA NA
Net Change in Cash & Cash Equivalents NA NA NA NA

powered by Interactive Data

Income Statement 2009 2008 2007 2006
Sales 8.11 Bil. 14.37 Bil. 5.61 Bil. 6.36 Bil.
Gross Operating Profit 40.18 Bil. 34.25 Bil. 42.76 Bil. 44.94 Bil.
Operating Income before D & A (EBITDA) 17.7 Bil. 10.53 Bil. 19.58 Bil. 20.5 Bil.
Total Income Before Interest Expenses (EBIT) 17.7 Bil. 9.47 Bil. 13.52 Bil. 12 Bil.
Total Net Income 8.1 Bil. 7.68 Bil. 19.34 Bil. 8.08 Bil.
Basic EPS, Total 1.2 1.2 2.67 1.1
Diluted EPS, Total 1.2 1.2 2.66 1.09

BALANCE STATEMENT 2009 2008 2007 2006
Cash and Equivalents NA NA 1.83 Bil. 2.25 Bil.
Total Assets NA NA 46.95 Bil. 41.9 Bil.
Total Liabilities NA NA 21.39 Bil. 28.45 Bil.
Total Capitalization NA NA 76.9 Bil. 71.97 Bil.

Cash Flow 2009 2008 2007 2006
Net Cash From Continuing Operations NA NA 27.84 Bil. 14.73 Bil.
Net Cash From Investing Activities NA NA 5.1 Bil. -5.07 Bil.
Net Cash From Financing Activities NA NA -23.1 Bil. -9.22 Bil.
Net Change in Cash & Cash Equivalents NA NA -420 Mil. 439 Mil.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
178.74 Bil.
129.5 Bil.
115.31 Bil.
109.87 Bil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented

Newsletter Sign-Up
Subscribe
Newsletter Sign-Up
Subscribe